Intas Gets CDSCO Panel Nod to Conduct Phase III Trial of Pertuzumab Biosimilar for Breast Cancer Written By Dr. Divya Colin11 Jun 2025 5:45 PM ISTNew Delhi: Intas Pharmaceuticals has received approval from the Subject Expert Committee (SEC), functioning under the Central Drugs Standard...
Lupin's TB Drug Isoniazid Dispersible Tablets Cleared for Launch by CDSCO Panel Written By Dr. Divya Colin10 Jun 2025 5:30 PM ISTNew Delhi: In response to a proposal submitted by Lupin Limited, the Subject Expert Committee (SEC) operating under the Central Drugs Standard Control...
CDSCO Panel Approves Bayer's Real-World Use Study for Heart Failure Drug Vericiguat Written By Dr. Divya Colin8 Jun 2025 12:56 PM ISTNew Delhi: The Subject Expert Committee (SEC) under the Central Drugs Standard Control Organisation (CDSCO) has granted approval to Bayer...
CDSCO Panel Approves Updated Prescribing Information for AstraZeneca's Rosuvastatin (Crestor) Written By Dr. Divya Colin8 Jun 2025 12:43 PM ISTNew Delhi: The Subject Expert Committee (SEC) under the Central Drugs Standard Control Organisation (CDSCO) has granted approval for the updated...
SEC Approves Serum's Salk Polio Vaccine for Commercial Use, Recommends Phase I Trial for 21-valent Pneumococcal Vaccine Written By Dr. Kamal Kant Kohli5 Jun 2025 6:17 PM ISTNew Delhi: The Subject Expert Committee (SEC) on Vaccines under the Central Drugs Standard Control Organization (CDSCO) has recommended the conduct of...
CDSCO Panel Seeks Revised Protocol for Green Signal's BCG Vaccine PMS Study Written By Dr. Kamal Kant Kohli5 Jun 2025 10:45 AM ISTNew Delhi: The Subject Expert Committee (SEC) on Vaccines, operating under the Central Drugs Standard Control Organization (CDSCO), has reviewed the...
CDSCO Panel Recommends Phase III Trial of Tetanus Vaccine by Indian Immunologicals in Pregnant Women Written By Dr. Kamal Kant Kohli4 Jun 2025 3:33 PM ISTNew Delhi: The Subject Expert Committee (SEC) for Vaccines under the Central Drugs Standard Control Organisation (CDSCO) has recommended the conduct...
MSN Labs Gets SEC Nod to Conduct Phase III Trial of Semaglutide Written By Dr. Divya Colin4 Jun 2025 3:10 PM ISTNew Delhi: Reviewing the bioequivalence study of the antidiabetic drug Semaglutide of MSN Laboratories, the Subject Expert Committee (SEC) functional...
Revise Phase IV Protocol for Gliclazide-Sitagliptin FDC with Scientific Justification: SEC Tells Eris Written By Dr. Divya Colin4 Jun 2025 3:01 PM ISTNew Delhi: Reviewing the Phase IV clinical trial of Eris Lifesciences' Fixed Dose Combination (FDC) antidiabetic drug Gliclazide plus Sitagliptin, the...
Cipla Gets CDSCO Panel Nod To BE Study, Phase III Trial of Semaglutide for Weight Management Written By Dr. Divya Colin4 Jun 2025 2:52 PM ISTNew Delhi: Drug major Cipla has received approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control...
CDSCO Panel Approves BE Study for Alkem's Dapagliflozin, Pioglitazone, Metformin FDC, Seeks Revised Phase III Plan Written By Dr. Divya Colin2 Jun 2025 1:51 PM ISTNew Delhi: Alkem Laboratories has received approval from the Subject Expert Committee (SEC) under the Central Drug Standard Control Organisation...
Fresenius Told To Submit Approval Basis, Phase III Data for Calcium Chloride Dihydrate Infusion Proposal Written By Dr. Divya Colin1 Jun 2025 4:30 PM ISTNew Delhi: In response to the proposal presented by Fresenius Medical Care, the Subject Expert Committee (SEC) functional under the Central Drug...
